275 related articles for article (PubMed ID: 12359438)
1. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.
Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL
Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438
[TBL] [Abstract][Full Text] [Related]
2. A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02.
Robinson S; Charini WA; Newberg MH; Kuroda MJ; Lord CI; Letvin NL
J Virol; 2001 Nov; 75(21):10179-86. PubMed ID: 11581386
[TBL] [Abstract][Full Text] [Related]
3. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.
Newberg MH; McEvers KJ; Gorgone DA; Lifton MA; Baumeister SH; Veazey RS; Schmitz JE; Letvin NL
J Immunol; 2006 Jan; 176(1):319-28. PubMed ID: 16365424
[TBL] [Abstract][Full Text] [Related]
4. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
[TBL] [Abstract][Full Text] [Related]
5. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
[TBL] [Abstract][Full Text] [Related]
6. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI
J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176
[TBL] [Abstract][Full Text] [Related]
7. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
Allen TM; Sidney J; del Guercio MF; Glickman RL; Lensmeyer GL; Wiebe DA; DeMars R; Pauza CD; Johnson RP; Sette A; Watkins DI
J Immunol; 1998 Jun; 160(12):6062-71. PubMed ID: 9637523
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.
Martins MA; Tully DC; Cruz MA; Power KA; Veloso de Santana MG; Bean DJ; Ogilvie CB; Gadgil R; Lima NS; Magnani DM; Ejima K; Allison DB; Piatak M; Altman JD; Parks CL; Rakasz EG; Capuano S; Galler R; Bonaldo MC; Lifson JD; Allen TM; Watkins DI
J Virol; 2015 Nov; 89(21):10802-20. PubMed ID: 26292326
[TBL] [Abstract][Full Text] [Related]
10. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.
Cale EM; Bazick HS; Rianprakaisang TA; Alam SM; Letvin NL
J Immunol; 2011 Sep; 187(6):3300-13. PubMed ID: 21841125
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL
J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363
[TBL] [Abstract][Full Text] [Related]
12. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Letvin NL
J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
[TBL] [Abstract][Full Text] [Related]
13. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
[TBL] [Abstract][Full Text] [Related]
14. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
15. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
Loffredo JT; Sidney J; Wojewoda C; Dodds E; Reynolds MR; Napoé G; Mothé BR; O'Connor DH; Wilson NA; Watkins DI; Sette A
J Immunol; 2004 Oct; 173(8):5064-76. PubMed ID: 15470050
[TBL] [Abstract][Full Text] [Related]
16. CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
Allen TM; Mothé BR; Sidney J; Jing P; Dzuris JL; Liebl ME; Vogel TU; O'Connor DH; Wang X; Wussow MC; Thomson JA; Altman JD; Watkins DI; Sette A
J Virol; 2001 Jan; 75(2):738-49. PubMed ID: 11134287
[TBL] [Abstract][Full Text] [Related]
17. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
Kuroda MJ; Schmitz JE; Barouch DH; Craiu A; Allen TM; Sette A; Watkins DI; Forman MA; Letvin NL
J Exp Med; 1998 May; 187(9):1373-81. PubMed ID: 9565630
[TBL] [Abstract][Full Text] [Related]
19. The Mamu B 17-restricted SIV Nef IW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness.
Minang JT; Trivett MT; Coren LV; Barsov EV; Piatak M; Chertov O; Chertova E; Ott DE; Ohlen C
Virology; 2008 May; 375(1):307-14. PubMed ID: 18328525
[TBL] [Abstract][Full Text] [Related]
20. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
Allen TM; Jing P; Calore B; Horton H; O'Connor DH; Hanke T; Piekarczyk M; Ruddersdorf R; Mothé BR; Emerson C; Wilson N; Lifson JD; Belyakov IM; Berzofsky JA; Wang C; Allison DB; Montefiori DC; Desrosiers RC; Wolinsky S; Kunstman KJ; Altman JD; Sette A; McMichael AJ; Watkins DI
J Virol; 2002 Oct; 76(20):10507-11. PubMed ID: 12239328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
